Deep Learning-based System and AIDS-related Cytomegalovirus Retinitis
NCT ID: NCT04831333
Last Updated: 2021-07-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2021-04-01
2021-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Deep learning (DL) system has been developed for the automated detection of various eye diseases with high accuracy and efficiency, including diabetic retinopathy, glaucoma, age-related macular degeneration (AMD), papilledema, lattice degeneration and retinal breaks, from ocular fundus photographs. UWF imaging is a relatively new imaging modality for DL system but has also shown extraordinary talents in automatic retinal analysis With the press for routine CMVR screening in AIDS patients and the great capacity of DL system, the use of deep learning (DL) system to AIDS-related CMVR with Ultra-Widefield (UWF) fundus images is promising.
The investigators previously developed a DL system to detect AIDS-related CMVR. For further evaluating the applicability of the DL system, a prospective dataset is needed.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
AI Classifies Multi-Retinal Diseases
NCT04592068
Screening and Identifying Hepatobiliary Diseases Via Deep Learning Using Ocular Images
NCT04213183
Real-world of AI in Diagnosing Retinal Diseases
NCT05981950
Multi-modal Intelligent Diagnosis System for Multiple Ophthalmic Diseases
NCT07143851
Development and Validation of a Deep Learning System for Multiple Ocular Fundus Diseases Using Retinal Images
NCT04213430
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active CMVR
The UWF images of cytomegalovirus retinitis (CMVR) included various patterns: hemorrhagic necrotizing lesion, granular lesion, frosted branch angiitis, and optic neuropathy lesion. Active CMVR lesion was defined as obvious opacity (mild, moderate, severe, very severe)
Inactive CMVR
Inactive CMVR lesion was defined as a lack of opacity or questionable/equivocal activity.
Non-CMVR
The non-CMVR images included normal retina and other retinopathies such as HIV-related microvascular retinopathy, diabetic retinopathy, retinal detachment, vitreous hemorrhage.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. The UWF images with poor quality would be excluded.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beijing Tongren Hospital
OTHER
Kuifang Du
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kuifang Du
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kui-Fang Du
Role: STUDY_DIRECTOR
Beijing YouAn Hospital
Li Dong
Role: STUDY_DIRECTOR
Beijing Tongren Hospital
Kai Zhang
Role: PRINCIPAL_INVESTIGATOR
Beijing Tongren Hospital
Chao Chen
Role: PRINCIPAL_INVESTIGATOR
Beijing YouAn Hospital
Lian-Yong Xie
Role: PRINCIPAL_INVESTIGATOR
Beijing YouAn Hospital
Wen-Jun Kong
Role: PRINCIPAL_INVESTIGATOR
Beijing YouAn Hospital
Hong-Wei Dong
Role: PRINCIPAL_INVESTIGATOR
Beijing YouAn Hospital
He-Yan Li
Role: PRINCIPAL_INVESTIGATOR
Beijing Tongren Hospital
Rui-Heng Zhang
Role: PRINCIPAL_INVESTIGATOR
Beijing Tongren Hospital
Wen-Da Zhou
Role: PRINCIPAL_INVESTIGATOR
Beijing Tongren Hospital
Hao-Tian Wu
Role: PRINCIPAL_INVESTIGATOR
Beijing Tongren Hospital
Wen-Bin Wei
Role: STUDY_CHAIR
Beijing Tongren Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beijing Youan Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20210331001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.